Key result
Stent thrombosis occurred predominantly in patients receiving single or dual antiplatelet therapy, with underlying mechanical abnormalities identified by OCT in 96.7% of cases.
Why the study?
Does the antiplatelet therapy regimen correlate with specific underlying mechanical abnormalities in patients with stent thrombosis?
Observational (n=120)
Blinded core laboratory
Yes
Does the antiplatelet therapy regimen correlate with specific underlying mechanical abnormalities in patients with stent thrombosis?
Stent thrombosis is almost universally associated with underlying mechanical abnormalities detectable by OCT, regardless of the patient's antiplatelet therapy regimen.
Answers are grounded in this paper and cite their sources.
Mechanical factors predominate in stent thrombosis despite antiplatelet therapy; hypothesis-generating for OCT-guided strategies in future trials.
BACKGROUND: Stent thrombosis (ST) may be triggered by different phenomena, including underlying device abnormalities and modification of the antiplatelet therapy (APT) regimen. This work investigated the characteristics of APT regimens and their relationships with ST mechanisms among a large cohort of patients evaluated by optical coherence tomography (OCT). METHODS AND RESULTS: A prospective multicenter registry was screened for patients with confirmed ST. OCT was performed after the initial intervention to the culprit lesion. ST was classified as acute (AST), subacute (SAST), late (LST) and very late (VLST). OCT records were analyzed in a central core laboratory. A total of 120 patients (median age 62 years, 89% male) were included in the study. VLST was the clinical presentation in 75%, LST in 6% and SAST+AST in 19% of the patients. Single APT (SAPT) was given in 61%, double APT (DAPT) in 27% and no APT in 12% of the cases at the time of the ST. A recent (≤15 days) APT modification was reported in 22% of the patients. An underlying mechanical abnormality was identified by OCT in 96.7% of the cases. Ruptured neoatherosclerotic lesions were significantly more frequent in patients without APT compared with the others. CONCLUSIONS: ST mostly occurs in patients receiving DAPT or SAPT. Any underlying mechanical abnormality of ST can be involved, irrespective of the APT regimen.
No takes yet. Share an insight, caveat, or question.
Amabile et al. (2017) conducted an observational in Stent thrombosis (n=120). Antiplatelet therapy regimen (DAPT, SAPT, or no APT) vs. Comparison between regimens was evaluated on Ruptured neoatherosclerotic lesions (p=0.03). Stent thrombosis occurred predominantly in patients receiving single or dual antiplatelet therapy, with underlying mechanical abnormalities identified by OCT in 96.7% of cases.
Synapse has enriched 10 related papers. Consider them for comparative context: